Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MyoKardia Inc. MYOK

Healthcare Biotechnology
"MyoKardia Inc is a US-based clinical-stage biopharmaceutical company which is engaged in discovering, developing and commercializing targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. The company mainly focuses on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac... see more

Recent & Breaking News (NDAQ:MYOK)

Mid-Afternoon Market Update: Armstrong Flooring Drops After Q2 Results; Myokardia Shares Climb

Benzinga.com  August 7, 2017

Mid-Day Market Update: NxStage Medical Surges Following Acquisition News; Gemphire Therapeutics Shares Drop

Benzinga.com  August 7, 2017

Mid-Morning Market Update: Markets Edge Higher; Tyson Foods Beats Q3 Estimates

Benzinga.com  August 7, 2017

MyoKardia Reports Second Quarter 2017 Financial Results and Operational Progress

GlobeNewswire August 7, 2017

MyoKardia Reports Positive Topline Results in Phase 2 PIONEER-HCM Study of Mavacamten (Formerly MYK-461) in Symptomatic, Obstructive Hypertrophic Cardiomyopathy

GlobeNewswire August 7, 2017

MyoKardia to Announce Second Quarter 2017 Financial Results and Host Conference Call on Monday, August 7, 2017

GlobeNewswire July 31, 2017

MyoKardia Reports First Quarter 2017 Financial Results and Operational Progress

GlobeNewswire May 9, 2017

Investor Network: MyoKardia, Inc. to Host Earnings Call

Accesswire May 9, 2017

MyoKardia to Announce First Quarter 2017 Financial Results and Host Conference Call on Tuesday, May 9, 2017

GlobeNewswire May 2, 2017

MyoKardia Appoints Kim Popovits and Wendy Yarno to Board of Directors

GlobeNewswire March 17, 2017

MyoKardia Reports Fourth Quarter and Full Year 2016 Financial Results and Operational Progress

GlobeNewswire March 13, 2017

MyoKardia to Present at Cowen and Company 37th Annual Health Care Conference

GlobeNewswire February 28, 2017

First Subjects Dosed in Phase 1 Study of Dilated Cardiomyopathy Candidate MYK-491

GlobeNewswire February 2, 2017

MyoKardia Announces Appointment of June Lee, M.D., as Chief Operating Officer and Radhika Tripuraneni, M.D., as Vice President, Medical Affairs

GlobeNewswire February 1, 2017

MyoKardia Announces Advancement to Next Phase of Global Collaboration with Sanofi

GlobeNewswire January 3, 2017

MyoKardia to Present at 2016 BMO Capital Markets Healthcare Conference

GlobeNewswire December 8, 2016

MyoKardia Announces Receipt of Milestone Payment from Sanofi for DCM Candidate MYK-491

GlobeNewswire December 2, 2016

MyoKardia Announces Appointment of Marc Semigran, M.D., as Chief Medical Officer

GlobeNewswire December 1, 2016

MyoKardia Announces Exploratory Digital Health Substudy as Part of PIONEER-HCM Trial of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients

GlobeNewswire November 11, 2016

MyoKardia Reports Progress on Clinical Programs and Third Quarter 2016 Financial Results

GlobeNewswire November 7, 2016